The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Inhibition of monoamine oxidase B in the brains of smokers
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Oxidative processes and antioxidative defense mechanisms in the aging brain 1
Reiter, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737461 · Cited by 806
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 638
Pharmacology and Therapeutics.
(1886) · The Lancet · doi:10.1016/s0140-6736(02)13327-7 · Cited by 527
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Riederer, P., & Youdim, M. B. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01747.x · Cited by 245
Cited by
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,206
The addicted human brain: insights from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18533 · Cited by 916
Self-citationThe dopamine theory of addiction: 40 years of highs and lows
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3939 · Cited by 649
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
Binda, C., Newton-Vinson, P., Hubálek, F., Edmondson, D. E., & Mattevi, A. (2002) · Nature Structural Biology · doi:10.1038/nsb732 · Cited by 644
Major Depression and Stages of Smoking: A Longitudinal Investigation
Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.161 · Cited by 633
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Behavioral and Neural Consequences of Prenatal Exposure to Nicotine
ERNST, M., MOOLCHAN, E. T., & ROBINSON, M. L. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00007 · Cited by 590
Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Brady, K. T., & Sinha, R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1483 · Cited by 552
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498
Epidemiology of Parkinson's disease
Elbaz, A., Carcaillon, L., Kab, S., & Moisan, F. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2015.09.012 · Cited by 445
Brain monoamine oxidase A inhibition in cigarette smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14065 · Cited by 423
Self-citationCheckoway, H., Powers, K., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., & Swanson, P. D. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.8.732 · Cited by 369
Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 361
Addressing tobacco among individuals with a mental illness or an addiction
Williams, J. M., & Ziedonis, D. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.03.009 · Cited by 359
Nicotine and nonnicotine factors in cigarette addiction
Rose, J. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0250-x · Cited by 349
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Ng, K. P., Pascoal, T. A., Mathotaarachchi, S., Therriault, J., Kang, M. S., Shin, M., Guiot, M.-C., Guo, Q., Harada, R., Comley, R. A., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0253-y · Cited by 346
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 324
Reduced Central Serotonin Transporters in Alcoholism
Heinz, A., Ragan, P., Jones, D. W., Hommer, D., Williams, W., Knable, M. B., Gorey, J. G., Doty, L., Geyer, C., Lee, K. S., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1544 · Cited by 308
Imaging the Addicted Human Brain
Fowler, J., Volkow, N., Kassed, C., & Chang, L. (2007) · Science & Practice Perspectives · doi:10.1151/spp07324 · Cited by 302
Self-citationZiedonis, D. M., & George, T. P. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.247 · Cited by 278
Klungsøyr, O., Nygård, J. F., Sørensen, T., & Sandanger, I. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj058 · Cited by 269
A genetic association for cigarette smoking behavior.
Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Lucas, F. R., IV, et al. (1999) · Health Psychology · doi:10.1037//0278-6133.18.1.7 · Cited by 270
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Meyer, J. H., Cervenka, S., Kim, M.-J., Kreisl, W. C., Henter, I. D., & Innis, R. B. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30255-8 · Cited by 270
Vascular damage from smoking: disease mechanisms at the arterial wall
Powell, J. T. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300105 · Cited by 269
Newhouse, P. A., Potter, A., & Levin, E. D. (1997) · Drugs & Aging · doi:10.2165/00002512-199711030-00005 · Cited by 267
Herraiz, T., & Chaparro, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.033 · Cited by 258
Increased stress response and β–phenylethylamine in MAOB–deficient mice
Grimsby, J., Toth, M., Chen, K., Kumazawa, T., Klaidman, L., Adams, J. D., Karoum, F., Gal, J., & Shih, J. C. (1997) · Nature Genetics · doi:10.1038/ng1097-206 · Cited by 258
Nicotine addiction: the possible role of functional upregulation
Buisson, B., & Bertrand, D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01979-9 · Cited by 254
Age-Related Increases in Brain Monoamine Oxidase B in Living Healthy Human Subjects
Fowler, J. S., Volkow, N. D., Wang, G.-J., Logan, J., Pappas, N., Shea, C., & MacGregor, R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00037-7 · Cited by 252
Self-citationMonoamine oxidase and cigarette smoking
Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(02)00109-2 · Cited by 251
Self-citationMetabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Dinis-Oliveira, R. J. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1278228 · Cited by 224
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
Moylan, S., Jacka, F. N., Pasco, J. A., & Berk, M. (2013) · Brain and Behavior · doi:10.1002/brb3.137 · Cited by 186
Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0948 · Cited by 186
Smoking and the Risk of Suicidal Behavior: A Prospective Study of a Community Sample
Breslau, N., Schultz, L. R., Johnson, E. O., Peterson, E. L., & Davis, G. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.328 · Cited by 175
Biological Aspects of the Link between Smoking and Depression
Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176
High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers
Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164
Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Reduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
Return to Smoking Following a Smoke‐Free Psychiatric Hospitalization
Prochaska, J. J., Fletcher, L., Hall, S. E., & Hall, S. M. (2006) · The American Journal on Addictions · doi:10.1080/10550490500419011 · Cited by 128
Prior cigarette smoking initiation predicting current alcohol use
Chen, X., Unger, J. B., Palmer, P., Weiner, M. D., Johnson, C. A., Wong, M. M., & Austin, G. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00211-8 · Cited by 112
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
McClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0516-y · Cited by 106
Lotfipour, S., Ferguson, E., Leonard, G., Perron, M., Pike, B., Richer, L., Séguin, J. R., Toro, R., Veillette, S., Pausova, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.124 · Cited by 102
The effect of stopping smoking on perceived stress levels
Hajek, P., Taylor, T., & McRobbie, H. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02979.x · Cited by 99
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., Tatsch, K., & Ackenheil, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002821 · Cited by 88
Translational neuroimaging: positron emission tomography studies of monoamine oxidase
Fowler, J. S., Logan, J., Volkow, N. D., & Wang, G.-J. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0016-1 · Cited by 81
Self-citationComparison of the reinforcing properties of nicotine and cigarette smoke extract in rats
Costello, M. R., Reynaga, D. D., Mojica, C. Y., Zaveri, N. T., Belluzzi, J. D., & Leslie, F. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.31 · Cited by 78
dos Santos, E. F., Busanello, E. N. B., Miglioranza, A., Zanatta, Â., Barchak, A. G., Vargas, C. R., Saute, J., Rosa, C., Carrion, M. J., Camargo, D., et al. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-009-9139-4 · Cited by 76
Psychosocial and Pharmacologic Explanations of Nicotine's “Gateway Drug” Function
Lindsay, G. B., & Rainey, J. (1997) · Journal of School Health · doi:10.1111/j.1746-1561.1997.tb03430.x · Cited by 65
Ghavami, A., Khorvash, F., Heidari, Z., Khalesi, S., & Askari, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105668 · Cited by 62
Dopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study
Bloomfield, M. A., Pepper, F., Egerton, A., Demjaha, A., Tomasi, G., Mouchlianitis, E., Maximen, L., Veronese, M., Turkheimer, F., Selvaraj, S., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.87 · Cited by 48
Pedersen, K., Simonsen, M., Østergaard, S. D., Lajord Munk, O., Rosa-Neto, P., Olsen, A. K., Jensen, S. B., Møller, A., & Cumming, P. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.038 · Cited by 37
Jensen, S. B., Olsen, A. K., Pedersen, K., & Cumming, P. (2006) · Synapse · doi:10.1002/syn.20258 · Cited by 27
Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Brady, K. T., & Sinha, R. (2007) · Focus · doi:10.1176/foc.5.2.foc229 · Cited by 12
Metadata
- Authors
- Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., Warner, D., Zezulkova, I., & Cilento, R.
- Venue
- Nature
- Published
- 1996-02
- Volume
- 379
- Issue
- 6567
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982164956
- Cited by
- 656
- References
- 27
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.